Sitc 2025 Conference Room. Sitc 2025 Meeting Audi Koressa SITC 2025 is held in Washington DC, United States, from 11/5/2025 to 11/5/2025 in Gaylord National Resort and Convention Center. 40th Annual Meeting & Pre-Conference Programs of the The Society for Immunotherapy of Cancer (SITC 2025) Date: Nov 5 - 9, 2025
Sitc 2024 Conference Room Edie Sherline from cecilykristal.pages.dev
Make your mark at the largest cancer immunotherapy conference and exhibit at SITC's 40 th Anniversary Annual Meeting, hosted by the leading member-driven organization focused on cancer immunotherapy, SITC.At SITC's Annual Meeting, we will bring together international leaders from academia, regulatory and government agencies, as well as industry representatives for unmatched education. 40th Annual Meeting & Pre-Conference Programs of the The Society for Immunotherapy of Cancer (SITC 2025) Date: Nov 5 - 9, 2025
Sitc 2024 Conference Room Edie Sherline
The 2025 SITC Spring Scientific, Cellular Therapy for Solid Tumors, will address the recent advances in adoptive cellular therapy for solid tumors and rate-limiting challenges that impede bringing these novel therapies to patients in need. We're excited to announce that SciLeads will be attending the SITC 2025 Spring Scientific Meeting, hosted by the Society for Immunotherapy of Cancer (SITC) SITC 2025 is held in Washington DC, United States, from 11/5/2025 to 11/5/2025 in Gaylord National Resort and Convention Center.
Sitc Conference 2025 Hedda Eachelle. 40th Annual Meeting & Pre-Conference Programs of the The Society for Immunotherapy of Cancer (SITC 2025) Date: Nov 5 - 9, 2025 SITC 2025 Annual Meeting Schedule Friday, Nov.7-Sunday, Nov
ACBS World Conference 2025 Association for Contextual Behavioral Science. 2025 SITC Fellowships: $300,000 in Research Funding Available Stage one of the application process — a Letter of Intent — is due by March 12 at 11:59 p.m The 2025 SITC Spring Scientific, Cellular Therapy for Solid Tumors, will address the recent advances in adoptive cellular therapy for solid tumors and rate-limiting challenges that impede bringing these novel therapies to patients in need.